Ngā hua rapu - Jyun-Yan Yang

  • E whakaatu ana i te 1 - 3 hua o te 3
Whakamahine hua
  1. 1
    Efficacy and safety of galcanezumab for the prevention of episodic migraine: Results of the EVOLVE-2 Phase 3 randomized controlled clinical trial

    Efficacy and safety of galcanezumab for the prevention of episodic migraine: Results of the EVOLVE-2 Phase 3 randomized controlled clinical trial mā Vladimir Skljarevski, Manjit Matharu, Brian A. Millen, Michael H. Ossipov, Byung‐Kun Kim, Jyun Yan Yang

    I whakaputaina 2018
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  2. 2
    Phase 3 randomized, placebo-controlled study of galcanezumab in patients with chronic cluster headache: Results from 3-month double-blind treatment

    Phase 3 randomized, placebo-controlled study of galcanezumab in patients with chronic cluster headache: Results from 3-month double-blind treatment mā David W. Dodick, Peter J. Goadsby, Christian Lucas, Rigmor Jensen, Jennifer Bardos, James M. Martinez, Chunmei Zhou, Sheena K. Aurora, Jyun Yan Yang, Robert R. Conley, Tina M. Oakes

    I whakaputaina 2020
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  3. 3
    Trial of Galcanezumab in Prevention of Episodic Cluster Headache

    Trial of Galcanezumab in Prevention of Episodic Cluster Headache mā Peter J. Goadsby, David W. Dodick, Massimo Leone, Jennifer Bardos, Tina M. Oakes, Brian A. Millen, Chunmei Zhou, Sherie A. Dowsett, Sheena K. Aurora, Andrew H. Ahn, Jyun-Yan Yang, Robert R. Conley, James M. Martinez

    I whakaputaina 2019
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:

Ngā utauta rapu: